Q BioMed Inc. (QBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Oct 17, 2025, 2:21 PM EDT
Q BioMed Market Cap
Q BioMed has a market cap or net worth of $14.51 thousand as of October 17, 2025. Its market cap has decreased by -75.00% in one year.
Market Cap
14.51K
Enterprise Value
n/a
Revenue
209.29K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 17, 2015, Q BioMed's market cap has decreased from 12.19M to 14.51K, a decrease of -99.88%. That is a compound annual growth rate of -47.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 14.51K | 9,906.21% |
| Dec 31, 2024 | 145.00 | -99.75% |
| Dec 29, 2023 | 58.04K | -93.87% |
| Dec 30, 2022 | 947.29K | -92.38% |
| Dec 31, 2021 | 12.44M | -46.16% |
| Dec 31, 2020 | 23.10M | -38.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 749.94M |
| Elite Pharmaceuticals | 652.54M |
| Veradigm | 500.94M |
| Nika Pharmaceuticals | 495.49M |
| CytoDyn | 365.33M |
| Northwest Biotherapeutics | 360.44M |
| Silence Therapeutics | 301.35M |
| American Oncology Network | 291.58M |